European Commission to Reconsider Combustion-Engine Car Ban Amid Industry Pressure
The European Commission is expected to reverse its decision to ban the sale of new combustion-engine cars from 2035. This anticipated policy shift comes in response to significant pressure from Germany, Italy, and European automakers who are facing competitive challenges from Chinese and U.S. rivals. The reversal is part of a broader strategy to support the automotive industry in Europe, which is grappling with the transition to electric vehicles. Additionally, French pharmaceutical company Sanofi has announced that the FDA is likely to delay its decision on Tolebrutinib, a drug for treating primary progressive multiple sclerosis, with guidance expected by the end of the first quarter of 2026.